Tag: Cardiology
-
Novel Protein Interactions May Serve as Biomarker for Heart Disease
Investigators led by Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, have discovered previously unknown protein interactions in the heart’s atrium that are critical for normal heart function, according to findings published in the Proceedings of the National Academy of Sciences.
-
Semaglutide Trials Show Improvements in Cardiovascular Health, Quality of Life
Two years after the FDA’s approval of semaglutide for chronic weight management, Northwestern Medicine scientists remain at the forefront of investigating the drug’s potential in helping patients who are overweight or have obesity who also have other preexisting health conditions.
-
Investigating Drug Combinations for Heart Failure
A common diabetes medication may help some patients with treatment-resistant hypertension slightly lower their high blood pressure and lessen their risk of heart failure events such as stroke, according to an analysis of a clinical trial published in Circulation.
-
Aortic Valve Replacement Procedures Show Similar Long-Term Survival Rates
Patients with severe aortic stenosis who underwent a minimally invasive aortic valve replacement procedure had similar long-term survival rates compared to patients who underwent traditional surgery, according to a recent study published in The New England Journal of Medicine.
-
Predicting The Risk of Heart Disease — 10 Years Younger Than Before
For the first time in 10 years, the American Heart Association has updated the model to predict someone’s risk of developing heart disease.
-
Cut Salt, Cut Blood Pressure
Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, according to a new study published in JAMA.
-
Pre-Pregnancy Obesity Predicts Future Heart Health
A new Northwestern Medicine study has found obesity before pregnancy is the root cause of future cardiovascular disease, rather than pregnancy complications.
-
Investigating the Role of DNA Damage in Cardiac Hypertrophy
A novel cellular pathway regulates DNA damage and structural changes in cardiomyocytes which contributes to the development of cardiac hypertrophy according to a Northwestern Medicine study published in Circulation.
-
Weight Loss Drug May Help Patients with Heart Failure
The antidiabetic and weight loss drug semaglutide, sold under the brand names Ozempic and Wegovy, can also help patients with heart failure and obesity lose weight while also improving symptoms and increasing exercise capacity, according to a clinical trial published in the New England Journal of Medicine.
-
New Genetic Variants Associated with Resting Heart Rate and Cardiovascular Disease Risk
Investigators have identified more than 60 previously unknown genetic variants associated with resting heart rate that may also contribute to increased risk of cardiovascular disease, according to findings published in Nature Communications.
